Skip to main content
logo
Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
21.73
+0.32 (1.49%)
At close: Nov 10, 2026, 4:00 PM EST
21.10
-0.63 (-2.90%)
After-hours: Nov 10, 2026, 7:59 PM EST

Structure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-293.88-141.2-122.53-89.62-51.32-38.05
Depreciation & Amortization
1.911.6810.320.280.07
Other Amortization
-----0.05
Loss (Gain) From Sale of Assets
-10.25-10.25----
Loss (Gain) From Sale of Investments
-12.57-15.59-18.47-5.98-0.910.03
Stock-Based Compensation
45.0728.9918.798.192.511.49
Other Operating Activities
2.782.211.60.630.350.19
Change in Accounts Receivable
--100----
Change in Accounts Payable
16.084.773.31-0.862.151.9
Change in Other Net Operating Assets
-20.157.19-0.347.830.822.17
Operating Cash Flow
-271-222.2-116.64-79.49-46.12-32.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.28-3.61-1.29-2.17-0.16-1.21
Sale of Property, Plant & Equipment
5.0910.25----
Investment in Securities
-314.7683.16-357.62-266.18-61.9519.07
Investing Cash Flow
-315.9589.8-358.91-268.34-62.1117.86

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
710.43765.15517.06473.10.030.01
Repurchase of Common Stock
-3.07-0.62---0.01-
Other Financing Activities
-1.29-2.02-1.8-21.57-2.513.24
Financing Cash Flow
706.06762.52515.26451.5329.01103.25

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
119.12630.1139.72103.7-79.2188.95

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-277.28-225.81-117.93-81.66-46.28-33.37
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.94-3.81-2.24-2.22-14.48-12.30
Levered Free Cash Flow
-165.06-180.03-70.78-51.38-26.08-18.79
Unlevered Free Cash Flow
-165.06-180.03-70.78-51.38-26.08-18.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-4.07-88.042.966.972.974.06
SEC Filings: 10-K · 10-Q